Sponsor or institution

Clinical trials and research at NextPoint Therapeutics, Inc.

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• NPX372 in selected solid tumors

  This early-stage study tests NPX372, a bispecific antibody, to see if it is safe and can help people with certain advanced solid tumors whose disease has not responded to standard therapy.

  Recruiting at 6 sites Phase 1 NextPoint Therapeutics, Inc. · La Jolla, California and 5 other locations · NCT07563829

• NPX887 treatment for solid tumors expressing B7-H7/HHLA2

  This study is testing a new treatment called NPX887 for people with solid tumors that have a specific marker to see if it helps shrink the tumors and how much of the drug is safe to use.

  Recruiting at 2 sites Phase 1 NextPoint Therapeutics, Inc. · Baltimore, Maryland and 7 other locations · NCT06240728

Quick answers

How many clinical trials run by NextPoint Therapeutics, Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →